Miller K W
Department of Anaesthesia and Critical Care, Massachusetts General Hospital, Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Br J Anaesth. 2002 Jul;89(1):17-31. doi: 10.1093/bja/aef167.
The molecular nature of the site of general anaesthesia has long been sought through the process of comparing the in vivo potencies of general anaesthetics with their physical properties, particularly their ability to dissolve in solvents of various polarities. This approach has led to the conclusion that the site of general anaesthesia is largely apolar but contains a strong polar component. However, there is growing evidence that several physiological targets underlie general anaesthesia, and that different agents may act selectively on subsets of these targets. Consequently research now focuses on the details of general-anaesthetic-protein interactions. There are large amounts of structural data that identify cavities where anaesthetics bind on soluble proteins that are readily crystallizable. These proteins serve as models, having no role in anaesthesia. Two problems make studies of the more likely targets--excitable membrane proteins--difficult. One is that they rarely crystallize and the other is that the sites have their highest affinity for general anaesthetics when the channels are in the open state. Such states rarely exist for more than tens of milliseconds. Crystallographers are making progress with the first problem, whilst anaesthesia researchers have developed a number of strategies for addressing the second. Some of these (kinetic analysis, site-directed mutagenesis) provide indirect evidence for sites and their nature, whilst others seek direct identification of sites by employing newly developed general anaesthetics that are photoaffinity labels. Such studies on acetylcholine, glycine and GABA receptors point to the existence of sites located within the plane of the membrane either within the ion channel lumen (acetylcholine receptor), or on the outer side of the alpha-helix lining that lumen (GABAA and glycine receptors). Bound anaesthetics generally exert their actions on ion channels by binding to allosteric sites whose topology varies from one conformation to another, but definitive proof for this mechanism remains elusive.
长期以来,人们一直通过比较全身麻醉药的体内效价与其物理性质,特别是它们在各种极性溶剂中的溶解能力,来探寻全身麻醉作用位点的分子本质。这种方法得出的结论是,全身麻醉作用位点在很大程度上是非极性的,但含有一个强极性成分。然而,越来越多的证据表明,全身麻醉有几个生理靶点作为基础,而且不同的药物可能选择性地作用于这些靶点的不同子集。因此,现在的研究集中在全身麻醉药与蛋白质相互作用的细节上。有大量的结构数据确定了麻醉药在易于结晶的可溶性蛋白质上结合的腔隙。这些蛋白质仅作为模型,在麻醉中并无作用。有两个问题使得对更有可能的靶点——可兴奋膜蛋白——的研究变得困难。一个问题是它们很少结晶,另一个问题是当通道处于开放状态时,这些位点对全身麻醉药具有最高亲和力。而这种状态很少能持续超过几十毫秒。晶体学家在解决第一个问题方面取得了进展,同时麻醉学研究人员已经开发出一些策略来解决第二个问题。其中一些方法(动力学分析、定点诱变)为作用位点及其性质提供了间接证据,而另一些方法则通过使用新开发的作为光亲和标记物的全身麻醉药来直接鉴定作用位点。对乙酰胆碱、甘氨酸和GABA受体的此类研究表明,在膜平面内存在作用位点,要么在离子通道腔内(乙酰胆碱受体),要么在构成该腔隙内衬的α-螺旋外侧(GABAA和甘氨酸受体)。结合的麻醉药通常通过与变构位点结合来对离子通道发挥作用,这些变构位点的拓扑结构在不同构象之间变化,但这种机制的确切证据仍然难以捉摸。